Post-earnings recap
Reported
Wed, Nov 14, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CorMedix Inc. reported an EPS of $-0.11, but did not provide revenue figures or guidance. Despite the lack of specific metrics, the stock rose by 2.73%, indicating that investors may have reacted positively to other underlying factors or future potential.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.11 | N/A | — |
| Revenue | — | N/A | — |
No transcript is on record, so the analysis is based solely on numerical results.